Trinity Capital provides $25M in growth capital to RxAnte

Trinity Capital announced a $25M facility to support the growth of RxAnte, a pharmacy care management business. $15M was drawn under the facility, and RxAnte has the option to draw an additional $10M, subject to the conditions under the agreement. RxAnte improves prescription drug use for regional and national health plans covering over 30 million lives. The company uses patented analytic technology and targeted clinical services to lower costs, improve quality scores, and enhance member experience. RxAnte expects to use investment proceeds for scaling operations to support accelerating growth, particularly for the company’s value-based pharmacy service aimed at medically complex and vulnerable Medicare beneficiaries.